Taken together, in addition to the overlapping clinical manifestation with STL1, OSCDP and other type II collagenopathies, the patients of this study present with pronounced skeletal features, resembling MFS or—to a minor extent—LDS3 (Table 2). This evidence concerns the gene COL2A1 and type 2 collagenopathy.